Use of tamoxifen in advanced-stage hepat
β
Anna K. Nowak; Martin R. Stockler; Pierce K. H. Chow; Michael Findlay
π
Article
π
2005
π
John Wiley and Sons
π
English
β 126 KB
## Abstract ## BACKGROUND Hepatocellular carcinoma (HCC) is the third most common cause of cancer mortality worldwide. Survival is poor for patients with advancedβstage HCC, and small trials of tamoxifen for patients with this disease have shown conflicting results. The authors conducted a systema